Target intelligence / Profile preview

19S proteasome AAA-ATPase subunits (PSMC1-PSMC6) (PSMC)

Target
PSMC
Molecular classification
Enzyme, AAA+ ATPase, Proteasome subunit
01

Overview

The AAA+ ATPase subunits of the 19S regulatory proteasome particle, comprising PSMC1 through PSMC6, form a hexameric ring that serves as the mechanical engine of the 26S proteasome (Source: UniProt). These subunits utilize ATP hydrolysis to recognize, unfold, and translocate polyubiquitinated protein substrates into the 20S core for degradation (Source: Annual Review of Biochemistry, PMID: 30089918). This process is essential for maintaining cellular proteostasis and regulating key processes such as the cell cycle and DNA repair (Source: PNAS, PMID: 27851968). In cancers like multiple myeloma, the proteasome is often upregulated, making these subunits attractive therapeutic targets (Source: Frontiers in Oncology, PMID: 32983998). While current clinical inhibitors like bortezomib target the 20S core, the 19S ATPases are emerging as targets for novel small molecules designed to overcome drug resistance (Source: Journal of Medicinal Chemistry, PMID: 29161035). Inhibition of these ATPases leads to the accumulation of misfolded proteins and triggers apoptosis via the unfolded protein response (Source: Cell Death & Disease, PMID: 23154387).

Other names
Rpt subunitsRegulatory particle triple-A ATPase subunits26S proteasome ATPase subunitsPSMC1-PSMC619S ATPase ringProteasome 26S subunit, ATPase
02

Mechanism of action

Inhibition of ATP-dependent protein unfolding and translocation into the 20S proteasome core, leading to proteotoxic stress and apoptosis.

03

Biological functions

Protein unfoldingSubstrate translocationProteostasisCell cycle regulationDNA repairProtein degradation
04

Disease associations

CancerMultiple myelomaNeurodegenerative diseaseInflammation
05

Safety considerations

Systemic toxicityPeripheral neuropathyThrombocytopeniaOff-target effects on other AAA+ ATPases
06

Interacting drugs

Bortezomib

3 more in the full profile.

07

Biomarkers

Ubiquitin-conjugate accumulationPSMC expression levelsProteasome activity assays

Beyond the preview

Go deeper on 19S proteasome AAA-ATPase subunits (PSMC1-PSMC6) (PSMC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 19S proteasome AAA-ATPase subunits (PSMC1-PSMC6) (PSMC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call